Shanghai Fosun Pharmaceutical Group Co Ltd (600196) — Cash Flow Reinvestment Rate
Shanghai Fosun Pharmaceutical Group Co Ltd (600196) has a Cash Flow Reinvestment Rate of 0.85x as of December 2025, reinvesting CN¥2.03 Billion (capex CN¥1.28 Billion plus investments CN¥753.03 Million) from operating cash flow of CN¥2.40 Billion. Explore Shanghai Fosun Pharmaceutical Group Co L capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai Fosun Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (1998–2025)
Historical reinvestment intensity for Shanghai Fosun Pharmaceutical Group Co Ltd across 28 annual periods. Also explore 600196 asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Shanghai Fosun Pharmaceutical Group Co Ltd (1998–2025)
Year-by-year capital reinvestment analysis for Shanghai Fosun Pharmaceutical Group Co Ltd. For live market cap and broader valuation context, see Shanghai Fosun Pharmaceutical Group Co L stock valuation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.12x | CN¥6.75 Billion | CN¥6.01 Billion | CN¥4.45 Billion | ▼ -0.5% |
| 2024 | 1.13x | CN¥5.06 Billion | CN¥4.48 Billion | CN¥4.41 Billion | ▼ -46.1% |
| 2023 | 2.10x | CN¥9.16 Billion | CN¥4.36 Billion | CN¥5.34 Billion | ▼ -0.7% |
| 2022 | 2.11x | CN¥8.91 Billion | CN¥4.22 Billion | CN¥5.89 Billion | ▲ +60.9% |
| 2021 | 1.31x | CN¥5.19 Billion | CN¥3.95 Billion | CN¥4.97 Billion | ▼ -34.1% |
| 2020 | 1.99x | CN¥5.14 Billion | CN¥2.58 Billion | CN¥4.44 Billion | ▼ -20.8% |
| 2019 | 2.52x | CN¥8.11 Billion | CN¥3.22 Billion | CN¥3.96 Billion | ▲ +42.6% |
| 2018 | 1.76x | CN¥5.21 Billion | CN¥2.95 Billion | CN¥3.17 Billion | ▲ +34.4% |
| 2017 | 1.31x | CN¥3.39 Billion | CN¥2.58 Billion | CN¥2.17 Billion | ▼ -36.6% |
| 2016 | 2.07x | CN¥4.37 Billion | CN¥2.11 Billion | CN¥1.92 Billion | ▲ +41.5% |
| 2015 | 1.46x | CN¥2.37 Billion | CN¥1.62 Billion | CN¥1.24 Billion | ▲ +56.9% |
| 2014 | 0.93x | CN¥1.12 Billion | CN¥1.20 Billion | CN¥1.12 Billion | ▼ -9.3% |
| 2013 | 1.03x | CN¥1.04 Billion | CN¥1.01 Billion | CN¥1.04 Billion | ▼ -41.0% |
| 2012 | 1.74x | CN¥1.16 Billion | CN¥665.52 Million | CN¥1.16 Billion | ▼ -30.7% |
| 2011 | 2.52x | CN¥796.83 Million | CN¥316.65 Million | CN¥796.83 Million | ▲ +50.9% |
| 2010 | 1.67x | CN¥339.17 Million | CN¥203.36 Million | CN¥339.17 Million | ▲ +25.5% |
| 2009 | 1.33x | CN¥348.07 Million | CN¥261.87 Million | CN¥348.07 Million | ▲ +47.1% |
| 2008 | 0.90x | CN¥210.63 Million | CN¥233.04 Million | CN¥210.63 Million | ▼ -43.3% |
| 2007 | 1.59x | CN¥209.71 Million | CN¥131.48 Million | CN¥209.71 Million | ▲ +10.6% |
| 2006 | 1.44x | CN¥266.61 Million | CN¥184.91 Million | CN¥266.61 Million | ▲ +22.0% |
| 2005 | 1.18x | CN¥222.60 Million | CN¥188.35 Million | CN¥222.60 Million | ▲ +18.2% |
| 2004 | 1.00x | CN¥205.02 Million | CN¥205.10 Million | CN¥205.02 Million | ▼ -43.2% |
| 2003 | 1.76x | CN¥264.05 Million | CN¥150.14 Million | CN¥264.05 Million | ▲ +29.2% |
| 2002 | 1.36x | CN¥139.52 Million | CN¥102.47 Million | CN¥139.52 Million | ▼ -34.4% |
| 2001 | 2.08x | CN¥141.51 Million | CN¥68.15 Million | CN¥141.51 Million | ▲ +127.0% |
| 2000 | 0.91x | CN¥126.63 Million | CN¥138.43 Million | CN¥126.63 Million | ▼ -55.2% |
| 1999 | 2.04x | CN¥77.99 Million | CN¥38.20 Million | CN¥77.99 Million | ▲ +160.1% |
| 1998 | 0.79x | CN¥52.25 Million | CN¥66.55 Million | CN¥52.25 Million | — |